A growing chorus of economists and former officials in the US and Europe is urging Beijing to strengthen the yuan, warning that prolonged undervaluation may escalate trade tensions and distort China’s growth model https://t.co/xqafEm2Os8 ...

Uber Technologies (NASDAQ: UBER) has a bold new advocate in CNBC’s Jim Cramer, who believes the ridesharing giant could more than double in value.“I think Uber’s going to $200,” Cramer said during his “Mad Money” lightning round on July 23, calling the company a “cash flow juggernaut.” He urged investors to “go buy more here,” emphasizing that Uber’s business model makes it worth holding, even buying at current levels.The timing of his call is notable. When Cramer made those remarks, Uber was trading at $89 ...

Our quick-and-dirty guide to exchange-rate distortions concludes that the Taiwanese dollar is greatly undervalued against the greenback. See where other currencies stand https://t.co/0Sov1RkL2v ...

Our quick-and-dirty guide to exchange-rate distortions concludes that the Taiwanese dollar is greatly undervalued against the greenback. See where other currencies stand https://t.co/tR1NDFU9Dq ...

Market Valuation - The total cryptocurrency asset class is approximately at 3266 trillion [1] - The cryptocurrency asset class is undervalued by approximately 1823% [1] Investment Strategy - As long as the cryptocurrency asset class remains below the red line, Bitcoin is expected to outperform most of the rest of the market [1]

Group 1 - Collegium Pharmaceuticals (NASDAQ: COLL) stock is trading at over $30 per share, with a market capitalization just shy of $1 billion [1] - The company provides insights for both novice and experienced biotech investors, including catalysts to watch for and buy/sell ratings [1] - The investing group Haggerston BioHealth offers detailed reports on over 1,000 companies in the biotech, healthcare, and pharma sectors [1] Group 2 - The Q1 2025 quarterly report/10Q submission is referenced, indicating ongoing financial disclosures [1]